Drug products for nasal and pulmonary delivery
Arcinova, a Quotient Sciences company, support manufacturing drug products for dry powder inhalers (DPIs) and solutions/suspensions for inhalation.
Extensive expertise and capabilities for nasal and pulmonary delivery include:
- Preformulation and API characterisation
- Formulation and process development
- Inhaled device evaluation and selection
- Clinical manufacturing and supply (Phase I)
- Clinical pharmacology assessments
To learn more, visit arcinova.com